| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.006 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.079 | 0.008 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |